Allergan to cut over 1,000 jobs as it works to return to growth

Allergan Plc on Wednesday said it plans to cut over 1,000 jobs and eliminate an additional 400 currently open positions, as it works to cut costs in the face of new competition for its second most important drug, dry-eye treatment Restasis.

The company said the jobs and positions it plans to eliminate mostly focus on products and categories where the company has or expects to soon lose exclusivity.

The drugmaker said it expects to take a $125 million charge from the job cuts, primarily due to severance, most of which will be recorded in the fourth quarter of 2017.

TRENDING NOW

Sebi plans to introduce 'fast track' concept for public issuance of debt securities

China's consumer prices fall fastest in 3 years, factory-gate deflation deepens

Investors to focus on inflation data from India, US: Data

NT Awards 2023: Zee Business shines in five categories

Finance Ministry to empanel merchant bankers, law firms for disinvestment via OFS, dribbling

Animal Box Office Collection: Ranbir Kapoor-starrer touches Rs 600 crore mark worldwide | Check OTT release details

FPIs invest Rs 26,505 crore in equities in 1st six sessions of December

COVID-19 Update: India records 148 new coronavirus cases, infection tally stands at 4.50 crore

NPS (National Pension System): How to create a corpus of Rs 5 crore with Rs 442 investment/day? After retirement, you will get Rs 2.5 lakh every month

Delhi Weather Update: National Capital records minimum temperature at 8.5°C

CLAT 2023 result to be released today on consortiumofnlus.ac.in - Final answer key out

Tata Group submits application to set up semiconductor processing plant in Assam: CM Sarma

Need to follow consistent EV policy, no need for company-specific sops: FICCI EV Committee Chair

Government approves 100% packaging of food grains in jute bags

Manu Ahuja, CEO of Jubilant Agri and Consumer Products, passes away

Allergan said cost savings from this restructuring programme should be around $300 million to $400 million per year.

(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)